OppenheimJ.J.RuscettiF.W., 1997. Cytokines. In Medical Immunology. StitesD. P.TerrA. I.ParslowT. G., 9th ed.Appleton and Lange Stamford Connecticut, p.146.
2.
AbbasA.K.LichtmanA.H.PoberJ.S., 1991. Cells and tissues of the immune system. In Cellular and Molecular Immunology. AbbasA.K., ed. W.B. Saunders CompanyPhiladelphia, p. 14.
3.
YoshinoS.HayashiH.TanedaS.TakanoH.SagaiM.MoriY., 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol.15:13
4.
GioiaC.AgratiC.GolettiD.VincentiD.CarraraS.AmicosanteM.CasariniM.GiosueS.PuglisiG.RossiA.ColizziV.PucilloL.P.PocciaF., 2003. Different cytokine production and effector/memory dynamics of ab+ or gd+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int. J. Immunopathol. Pharmacol.16:247.
5.
HeS.C.QiaoN.ShengW., 2003. Neurobehavioral, autonomic nervous function and lymphocyte subsets among aluminum electrolytic workers. Int. J. Immunopathol. Pharmacol.16:139.
6.
KempurajD.HuangM.KandereK.BoucherW.LetourneauR.AthanasiouA.TheoharidesT.C., 2003. Azelastine inhibits synthesis and secretion of IL-6, IL-8 and TNF-α, by reducing intracellular calcium ion levels in human umbilical cord blood-derived cultured mast cells. Int. Arch. Allergy Immunol. 132:231.
7.
ArenaA.EnzoB.EnricoG.MarcoB.GraziellaR., 2003. Specific immunotherapy of allergic diseases: A three years perspective observational study. Int. J. Immunopathol. Pharmacol.16:277.
8.
KempurajD.DonelanJ.FrydasS.IezziT.ContiP.BoucherW.PapadoopoulouN. G.MadhappanB.LetourneauL.SabatinoG.TheoharidesT.C., 2004. Interleukin-28 and 29 (IL-28 and IL-29): New cytokines with anti-viral activities. Int. J. Immunopathol. Pharmacol.17:103.
KempurajD.FrydasS.ContiP.KandereK.BoucherW.LetourneauR.MadhappanB.HuangS.H.KoreakiS.ChristodoulouS.TheoharidesT.C., 2003. Interleukin-25: A new IL-17 family member with growth factor/inflammatory action. Int. J. Immunopathol. Pharmacol.16:185.
11.
Di GioacchinoM.VernaN.CavalluciE.PaoliniF.CarusoR.GranaM.SchiavoneC.Di IorioA.RamandoS.RealeM.PaganelliR.TheoharidesT. C., 2002. Steroid and antihistamines modulate RANTES release in cultured peripheral blood mononuclear cells of atopic patients. Int. J. Immunopathol. Pharmacol.15:27.
12.
ContiP.RealeM.BarbacaneR.C.CastellaniM.L.OrsoC., 2002. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol. Lett.80:105.
13.
BiswasS.K.SodhiA., 2002. Effect of monocyte chemoattractant protein-1 on murine bone marrow cells: Proliferation, colony forming ability signal transduction pathway involved. Int. J. Immunopathol. Pharmacol.15:183.
14.
PerrellaO.PerrellaM.CusumanoV.IbelloU.SbregliaC.De SenaR.PerrellaA., 2002. Interleukin-10 and transforming growth factor beta 1 in hepatic fibrosis. Int. J. Immunopathol. Pharmacol.15:243.
15.
HuangM.BerryJ.KandereK.LytinasM.KaralisK.TheoharidesT.C., 2002. Mast cell deficient W/Wv mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol.15:249.
16.
TheoharidesT.C.CochraneD., 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol.146:1
17.
DhabharF.S.2002. Stress-induced augmentation of immune function - the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav. Immun.16:785.
18.
HuangD.HanY.RaniM.R.GlabinskiA.TrebstC.SorensenT.TaniM.WangJ.ChienP.O'BryanS.BieleckiB.ZhouZ.L.MajumderS.RansohoffR.M., 2000. Chemokines and chemokine receptors in inflammation of the nervous system: Manifold roles and exquisite regulation. Immunol. Rev.177:52.
19.
PehlivanidisC.FotoulakiM.BoucherW.KempurajD.PangX.KostantinidouA.TheoharidesT.C., 2002. Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis. J. Clin. Psychopharmacol.22:221.
20.
TheoharidesT.C.2002. Mast cells and stress. A psychoneuroimmunological perspective. J. Clin. Psychopharmacol.22:103.
21.
HuangM.PangX.KaralisK.TheoharidesT.C., 2003. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in a lipoprotein E knockout mice. Cardiovascular Res. 59:241.
22.
Kandere-GrzybowskaK.LetourneauR.KempurajD.DonelanJ.PaplowskiS.BoucherW.AthanassiouA.TheoharidesT.C., 2003. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol.171:4830
23.
ChiappiniE.PeruzziM.GalliL.CalabriG.de MartinoM., 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with anticonvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol.15:239.
24.
ElenkovI.J.ChrousosG.P., 2002. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N.Y. Acad. Sci.966:290.
DunnA.J.WangJ.AndoT., 1999. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol.461:117.
27.
LicinioJ.WongM.L., 1999. Theroleofinflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry4:317.
28.
AnismanH.MeraliZ., 2003. Cytokines, stress and depressive illness: Brain-immune interactions. Ann. Med.35:2.
29.
TheoharidesT.C.Konstantinidou. 2003. Antidepressant and risk of cancer: A case of misguided associations and priorities. J. Clin. Psychopharmacol.23:1
30.
O'BrienS.M.ScottL.V.DinanT.G., 2004. Cytokines: Abnormalities in major depression and implications for pharmacological treatment. Hum. Psychopharmacol.19:397.
MennickenF.MakiR.de SouzaE.B.QuirionR., 1999. Chemokines and chemokine receptors in the CNS: A possible role in neuroinflammation and patterning. Trends Pharmacol. Sci.20:73
33.
Wada-IsoeK.WakutaniY.UrakamiK.NakashimaK., 2004. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol. Scand.110:124.
34.
CalabresiP.A.TranquillL.R.McFarlandH.F.CowanE.P., 1998. Cytokine gene expression in cells derived from CSF of multiple sclerosis patients. J. Neuroimmunol.89:198.
35.
AdikariS.B.PetterssonA.SoderstromM.HuangY.M.LinkH., 2004. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis. Scand. J. Immunol.59:600.
36.
LacheneckerP.BihlerI.WeberF.GottschalkM.ToykaK.V.RieckmannP., 2004. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult. Scler.10:165.
37.
ContiP.KempurajD.KandereK.Di GioacchinoM.BarbacaneR.C.CastellaniM.L.FelacoM.BoucherW.LetourneauR.TheoharidesT.C., IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol. Lett.86:123.
JungS.SiglientiI.GrauerO.MagnusT.ScarlatoG.ToykaK., Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate. J. Neuroimmunol.148:63.
40.
TheoharidesT.C.DonelanJ.M.PapadopoulouN.CaoJ.KempurajD.ContiP., 2004. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. (in press).
41.
de BoerA.G.BrimerD.D., 1998. Cytokines and blood-brain barrier permeability. Progress Brain Res. 115:425.
42.
EspositoP.ChandlerN.KandereK.BasuS.JacobsonS.ConnollyR.TutorD.TheoharidesT.C., 2002. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther.303:1061.
43.
CacquevelM.LebeurrierN.CheenneS.VivienD., 2004. Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets5:529.
44.
MichalopoulouM.NikolaouC.TavernarakisA.AlexandriNM.RentzosM.ChatzipanagiotouS.CambouriC.VassilopoulosD., 2004. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non-inflammatory neurological diseases. Immunol. Lett.94:183.
45.
ArosioB.TrabattoniD.GalimbertiL.BucciarelliP.FasanoF.CalabresiC.CazzulloC.L.VerganiC.AnnoniG.ClericiM., 2004. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging25:1009.
46.
ZhangY.HayesA.PritchardA.ThakerU.HaqueM.S.LemmonH.HarrisJ.CummingA.LambertJ.C.Chartier-HarlinM.C.St ClairD.IwatsuboT.MannD.M.LendonCL., 2004. Interleukin-6 promoter polymorphism: Risk and pathology of Alzheimer's disease. Neurosci. Lett.362:99.
47.
QuintanillaR.A.OrellanaD.I.Gonzalez-BillaultC.MaccioniR.B., 2004. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell. Res.295:245.